BIOPROCESSORS CORP.

12-A Cabot Road

Woburn, MA 01801 USA

Tel: (781) 935-1400

Fax: (781) 935-1450

GENERAL CONTACTS

URL: www.bioprocessors.com  

Bioprocessors has developed microfermentor technology which permits the growth of cell cultures under controlled conditions. The microfermentor permits the environment of a cell to be altered via computer control. An array of microfermentors under computer control permits a wide variety of cell and tissue experiments to be performed easily and simultaneously compared to older, bulkier and hence slower cell experimentation techniques.

MANAGEMENT

Andrey J. Zarur, President and CEO, Cofounder

Christianne Baruqui, Vice President Human Resources, Co-founder

James Hope, Ph.D., Vice President Operations

Seth T. Rodgers, Ph.D., Chief Technology Officer

H. Brett Schreyer, Ph.D., Vice President Biology

Erik Bates, Vice President Manufacturing

Scott D'Amour, Vice President Finance

George J. Vella, Ph.D., Vice President Research and Development

Stephen K. Tingley, Head of Commercial Development

Ian MacGregor, Head of Systems Automation

Kang Yu, M.D., Ph.D., Head of Discovery

Gennady Malin, Ph.D., Head of Development

Scott Miller, Ph.D., Head of Micro Engineering

A. Peter Russo, Ph.D., Director of Microfabrication

Mohamed Shaheen, Head of Software Development

FAST FACTS

Classification: Micromachines, MEMs, Bioprocessor Reaction Chamber, Private

Funding Report: 2003 (July), Series B

Investors Series B: Eastman Chemicals, Healthcare Ventures, Oxford Bioscience Partners

AGREEMENTS

Bioprocessors in 2003 entered into an agreement with Alexion Pharmaceuticals Inc. (Nasdq: ALXN) for the use of  BioProcessors' MicroFermentor Platform for the development of  microbial biopharmaceutical processes.

END MARKETS

ADME/Toxicology, Bioprocess Development, Clone Synthesys, Drug Discovery